Skip to main content
SpringerLink
Log in

Common Endocrinopathies in Reproductive Endocrinology

  • Chapter
  • First Online:
Reproductive Endocrinology and Infertility

  • 3009 Accesses

Abstract

This chapter reviews two of the most common endocrinopathies in reproductive medicine and highlights the unique associations with reproductive outcomes that should be appreciated by the reproductive endocrine clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7(6):481-493

    Article  CAS  Google Scholar 

  2. Whartona T (1659) Adenographoa: sive glandularum totius corporis descripto

    Google Scholar 

  3. Portmann L, Hamada N, Heinrich G, DeGroot LJ (1985) Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab 61(5):1001-1003

    Article  PubMed  CAS  Google Scholar 

  4. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190(1):147-152

    Article  PubMed  CAS  Google Scholar 

  5. Norman AW, Litwack G (1987) Thyroid hormones. In: Norman AW, Litwack G (eds) Hormones. Academic, San Diego, p 221

    Google Scholar 

  6. Kibirige MS, Hutchison S, Owen CJ, Delves HT (2004) Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus. Arch Dis Child Fetal Neonatal Ed 89(5):F436-F439

    Article  PubMed  CAS  Google Scholar 

  7. Asamer H, Riccabona G, Holthaus N, Gabl F (1968) Immunohistologic findings in thyroid disease in an endemic goiter area. Arch Klin Med 215(3):270-284

    PubMed  CAS  Google Scholar 

  8. Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M, Moulopoulos SD (1983) Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 57(4):859-862

    Article  PubMed  CAS  Google Scholar 

  9. Greer MA (1980) Antithyroid drugs in the treatment of thyrotoxicosis. Thyroid Today 3

    Google Scholar 

  10. McGregor MA, Weetman AP, Ratanchaiyavong S et al (1985) Iodide: as influence on the development of autoimune thyroid disease. In: Hall R, Kobberling J (eds) Thyroid disorders associated with iodine deficiency and excess. Raven, New York, pp 209-216

    Google Scholar 

  11. Weetman AP (2000) Graves’ disease. N Engl J Med 343(17):1236-1248

    Article  PubMed  CAS  Google Scholar 

  12. Allen EM, Appel MC, Braverman LE (1986) The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology 118(5):1977-1981

    Article  PubMed  CAS  Google Scholar 

  13. Sundick RS, Herdegen D, Brown TR (1986) Thyroiditis induced by dietary iodine may be due to the increased immunogenicity of highly iodinated thyroglobulin. In: Dexhage HA, Wiersinga WM (eds) The thyroid and autoimmunity. Elsevier Science, Amsterdam, New York, p 213

    Google Scholar 

  14. Bahn AK, Mills JL, Snyder PJ et al (1980) Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 302(1):31-33

    Article  PubMed  CAS  Google Scholar 

  15. Gaitan E, Cooksey RC, Legan J (1985) Simple goiter and autoimmune thyroiditis: environmental and genetic factors. Clin Ecol (3):158-162

    Google Scholar 

  16. Wenzel BE, Heesemann J (1987) Antigenic homologies between plasmid encoded proteins from enteropathogenic Yersinia and thyroid autoantigen. Horm Metab Res Suppl 17:77-78

    PubMed  CAS  Google Scholar 

  17. Caldwell G, Kellett HA, Gow SM et al (1985) A new strategy for thyroid function testing. Lancet 1(8438):1117-1119

    Article  PubMed  CAS  Google Scholar 

  18. Glinoer D, de Nayer P, Bourdoux P et al (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71(2):276-287

    Article  PubMed  CAS  Google Scholar 

  19. Panesar NS, Li CY, Rogers MS (2001) Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 38(Pt 4):329-332

    Article  PubMed  CAS  Google Scholar 

  20. Mehdi SR, Vasenwala SM, Zaheer MS, Vasenwala AM (2003) Role of FNAC and antithyroid antibodies in the diagnosis of thyroid disorders. Indian J Pathol Microbiol 46(2):184-190

    Article  PubMed  CAS  Google Scholar 

  21. Pandit AA, Vijay Warde M, Menon PS (2003) Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis. Diagn Cytopathol 28(2):63-65

    Article  PubMed  Google Scholar 

  22. Okamura K, Sato K, Yoshinari M, Ikenoue H, Kuroda T, Nakagawa M, Tsuji H, Washio M, Fujishima M (1990) Recovery of the thyroid function in patients with atrophic hypothyroidism and blocking type TSH binding inhibitor immunoglobulin. Acta Endocrinol (Copenh) 122(1): 107-114

    CAS  Google Scholar 

  23. Tang T, Wang YG, Tsuboi K, Irie M, Ma T, Ingbar SH (1991) Blocking type immunoglobulins in patients with nongoitrous primary hypothyroidism in area of iodine deficiency. Endocrinol Jpn 38(6):661-665

    PubMed  CAS  Google Scholar 

  24. Valente WA, Vitti P, Rotella CM, Vaughan MM, Aloj SM, Grollman EF, Ambesi-Impiombato FS, Kohn LD (1983) Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. N Engl J Med 309(17):1028-1034

    Google Scholar 

  25. Zakarija M, Jin S, McKenzie JM (1988) Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells. J Clin Invest. 81(3):879-884

    Article  PubMed  CAS  Google Scholar 

  26. Brezinschek HP, Wilders-Truschnig M, Leb G, Eber O, Dohr G, Lanzer G, Krejs GJ (1990) Thyroid growth promoting serum-IgG in endemic goiter. Acta Med Austriaca 17 Suppl 1:26-77

    PubMed  CAS  Google Scholar 

  27. Zakarija M, McKenzie JM (1990) Do thyroid growth-promoting immunoglobulins exist?J Clin Endocrinol Metab 70(2):308-310

    PubMed  CAS  Google Scholar 

  28. Gupta MK (1992) Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases. Clin Biochem 25(3):193-199

    CAS  Google Scholar 

  29. Vitti P, Chiovato L, Tonacchera M, Bendinelli G, Mammoli C, Capaccioli A, Fiore E, Pretell E, Pinchera A (1994) Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter. J Clin Endocrinol Metab 78(5):1020-1025

    PubMed  CAS  Google Scholar 

  30. Wilders-Truschnig MM, Warnkross H, Leb G, Langsteger W, Eber O, Tiran A, Dobnig H, Passath A, Lanzer G, Drexhage HA (1993) The effect of treatment with levothyroxine or iodine on thyroid size and thyroid growth stimulating immunoglobulins in endemic goitre patients. Clin Endocrinol (Oxf) 39(3):281-286

    PubMed  CAS  Google Scholar 

  31. Davies R, Lawry J, Bhatia V, Weetman AP (1995) Growth stimulating antibodies in endemic goitre: a reappraisal. Clin Endocrinol (Oxf) 43(2):189-195

    PubMed  CAS  Google Scholar 

  32. Vanderpump MPJ, Tunbridge WMG (1996) The thyroid: a fundamental and clinical text. In, 7th edn. Lippincott-Raven, Philadelphia, pp 474-482

    Google Scholar 

  33. Prummel MF, Wiersinga WM (2004) Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150(6):751-755

    Article  PubMed  CAS  Google Scholar 

  34. Haddow JE, Palomaki GE, Allan WC et al (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341(8):549-555

    Article  PubMed  CAS  Google Scholar 

  35. Abalovich M, Amino N, Barbour LA et al (2007) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92(8 Suppl):S1-S47

    PubMed  CAS  Google Scholar 

  36. American College of Obstetrics and Gynecology (2002) ACOG practice bulletin. Thyroid disease in pregnancy. Number 37, August 2002. Int J Gynaecol Obstet 79(2):171-180

    Article  Google Scholar 

  37. Kabadi UM (1993) ‘Subclinical hypothyroidism’. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 153(8):957-961

    Article  PubMed  CAS  Google Scholar 

  38. Grodstein F, Goldman MB, Ryan L, Cramer DW (1993) Self-reported use of pharmaceuticals and primary ovulatory infertility. Epidemiology 4(2):151-156

    Article  PubMed  CAS  Google Scholar 

  39. Morimoto C, Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD (1980) Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66(5):1171-1174

    Article  PubMed  CAS  Google Scholar 

  40. Lao TT, Chin RK, Panesar NS, Swaminathan R (1988) Observations on thyroid hormones in hyperemesis gravidarum. Asia Oceania J Obstet Gynaecol 14(4):449-452

    PubMed  CAS  Google Scholar 

  41. Albright F (1938) Metropathia hemorrhagica. Main MJ (29):235-238

    Google Scholar 

  42. Wilansky DL, Greisman B (1989) Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol 160(3):673-677

    PubMed  CAS  Google Scholar 

  43. Yamada T, Tsukui T, Ikejiri K, Yukimura Y, Kotani M (1976) Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab 42(5):817-822

    Article  PubMed  CAS  Google Scholar 

  44. Honbo KS, van Herle AJ, Kellett KA (1978) Serum prolactin levels in untreated primary hypothyroidism. Am J Med 64(5):782-787

    Article  PubMed  CAS  Google Scholar 

  45. Thomas R, Reid RL (1987) Thyroid disease and reproductive dysfunction. Obstet Gynecol (70):789-798

    Google Scholar 

  46. Scanlon MF, Chan V, Heath M et al (1981) Dopaminergic control of thyrotropin, alpha-subunit, thyrotropin beta-subunit, and prolactin in euthyroidism and hypothyroidism: dissociated responses to dopamine receptor blockade with metoclopramide in hypothyroid subjects. J Clin Endocrinol Metab 53(2):360-365

    Article  PubMed  CAS  Google Scholar 

  47. Kramer MS, Kauschansky A, Genel M (1979) Adolescent secondary amenorrhea: association with hypothalamic hypothyroidism. J Pediatr 94(2):300-303

    Article  PubMed  CAS  Google Scholar 

  48. Feek CM, Sawers JS, Brown NS, Seth J, Irvine WJ, Toft AD (1980) Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: evidence for an additional feedback mechanism in the control of thyroid hormone secretion. J Clin Endocrinol Metab 51(3):585-589

    Article  PubMed  CAS  Google Scholar 

  49. Keye WR, Yuen BH, Knopf RF, Jaffe RB (1976) Amenorrhea, hyperprolactinemia and pituitary enlargement secondary to primary hypothyroidism. Successful treatment with thyroid replacement. Obstet Gynecol 48(6):697-702

    PubMed  CAS  Google Scholar 

  50. del Pozo E, Wyss H, Tollis G, Alcaniz J, Campana A, Naftolin F (1979) Prolactin and deficient luteal function. Obstet Gynecol 53(3):282-286

    PubMed  Google Scholar 

  51. Bohnet HG, Fiedler K, Leidenberger FA (1981) Subclinical hypothyroidism and infertility. Lancet 2(8258):1278

    Article  PubMed  CAS  Google Scholar 

  52. Warfel W (1992) Thyroid regulation pathways and its effect on human luteal function. Gynakol Geburtshilfliche Rundsch (32):145-150

    Google Scholar 

  53. Walsh JP, Shiels L, Lim EM et al (2003) Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88(10):4543-4550

    Article  PubMed  CAS  Google Scholar 

  54. Davies TF, Roman SH, Mackenzie WA, Goldsmith N, Dower SM, Piccinini LA (1987) Thyroid cell MHC class II antigens: a perspective on the aetiology of autoimmune thyroid disease. Acta Endocrinol Suppl (Copenh) 281:13-20

    CAS  Google Scholar 

  55. Kong YC, Flynn JC, Wan Q, David CS (2003) HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36(6-7):397-404

    Article  PubMed  CAS  Google Scholar 

  56. Tomer Y, Blackard JT, Akeno N (2007) Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 36(4):1051-1066 x-xi

    Article  PubMed  CAS  Google Scholar 

  57. Vitti P, Rago T, Chiovato L et al (1997) Clinical features of patients with Graves’ disease undergoing remission after antithyroid drug treatment. Thyroid 7(3):369-375

    Article  PubMed  CAS  Google Scholar 

  58. Michelangeli V, Poon C, Taft J, Newnham H, Topliss D, Colman P (1998) The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves’ disease with antithyroid drugs. Thyroid 8(2):119-124

    Article  PubMed  CAS  Google Scholar 

  59. Schlumberger M, De Vathaire F, Ceccarelli C et al (1996) Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 37(4):606-612

    PubMed  CAS  Google Scholar 

  60. Edan G, Massart C, Hody B et al (1989) Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves’ disease. BMJ 298(6670):359-361

    Article  PubMed  CAS  Google Scholar 

  61. Iwatani Y (2004) Current topics on immunological laboratory tests-thyroid diseases. Rinsho Byori 52(9):751-758

    PubMed  CAS  Google Scholar 

  62. Padmanabhan LD, Mhaskar R, Mhaskar A, Vallikad E (2003) Trophoblastic hyperthyroidism. J Assoc Physicians India 51:1011-1013

    PubMed  CAS  Google Scholar 

  63. Yoshimura M, Hershman JM (1995) Thyrotropic action of human chorionic gonadotropin. Thyroid 5(5):425-434

    Article  PubMed  CAS  Google Scholar 

  64. Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE, Mitchell ML (2001) Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen 8(1):18-20

    Article  PubMed  CAS  Google Scholar 

  65. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR (2004) Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351(3):241-249

    Article  PubMed  CAS  Google Scholar 

  66. Zakarija M, McKenzie JM (1983) Thyroid-stimulating antibody (TSAb) of Graves’ disease. Life Sci 32(1-2):31-44

    Article  PubMed  CAS  Google Scholar 

  67. Zakarija M, Garcia A, McKenzie JM (1985) Studies on multiple thyroid cell membrane-directed antibodies in Graves’ disease. J Clin Invest 76(5):1885-1891

    Article  PubMed  CAS  Google Scholar 

  68. Tanaka T, Tamai H, Kuma K, Matsuzuka F, Hidaka H (1981) Gonadotropin response to luteinizing hormone releasing hormone in hyperthyroid patients with menstrual disturbances. Metabolism 30(4):323-326

    Article  PubMed  CAS  Google Scholar 

  69. Thomas R, Reid RL (1987) Thyroid disease and reproductive dysfunction: a review. Obstet Gynecol 70(5):789-798

    PubMed  CAS  Google Scholar 

  70. Bournaud C, Orgiazzi J (2003) Antithyroid agents and embryopathies. Ann Endocrinol (Paris) 64(5 Pt 1):366-369

    CAS  Google Scholar 

  71. Polak M, Le Gac I, Vuillard E et al (2004) Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab 18(2):289-302

    Article  PubMed  CAS  Google Scholar 

  72. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH (1994) Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84(6):946-949

    PubMed  CAS  Google Scholar 

  73. Mestman JH (2004) Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18(2):267-288

    Article  PubMed  CAS  Google Scholar 

  74. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG (1989) Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160(1):63-70

    PubMed  CAS  Google Scholar 

  75. Amino N, Mori H, Iwatani Y et al (1982) High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 306(14):849-852

    Article  PubMed  CAS  Google Scholar 

  76. Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988) The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol 159(1):203-209

    PubMed  CAS  Google Scholar 

  77. Iwatani Y, Amino N, Tamaki H et al (1988) Increase in peripheral large granular lymphocytes in postpartum autoimmune thyroiditis. Endocrinol Jpn 35(3):447-453

    PubMed  CAS  Google Scholar 

  78. Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG (1988) Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 67(2):327-333

    Article  PubMed  CAS  Google Scholar 

  79. Jansson R, Karlson A (1986) Autoimmune thyroid disease in pregnancy and the postpartum period. In: McGregory AM (ed) Immunology of endocrine disease. MTP Press, Lancaster, UK, pp 181-188

    Google Scholar 

  80. Walfish PG, Chan JY (1985) Post-partum hyperthyroidism. Clin Endocrinol Metab 14(2):417-447

    Article  PubMed  CAS  Google Scholar 

  81. Glinoer D, Soto MF, Bourdoux P et al (1991) Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 73(2):421-427

    Article  PubMed  CAS  Google Scholar 

  82. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264(11):1422-1425

    Article  PubMed  CAS  Google Scholar 

  83. Maier DB, Parke A (1989) Subclinical autoimmunity in recurrent aborters. Fertil Steril 51(2):280-285

    PubMed  CAS  Google Scholar 

  84. Magaro M, Zoli A, Altomonte L et al (1992) The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 10(1):67-70

    PubMed  CAS  Google Scholar 

  85. LaBarbera A, Miller MM, Ober C et al (1988) Autoimmunit etiology in premature ovarian failure. Am J Reprod Immunol (16):114-118

    Google Scholar 

  86. Peterson CM (1994) Thyroid disease and fertility. In Autoimmunity in Reproduction, Gleicher N (ed), Immunology and Allergy Clinics of North America WB Saunders, Philadelphia, Pa. 14:725-738.

    Google Scholar 

  87. Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154(16):1838-1840

    Article  PubMed  CAS  Google Scholar 

  88. McHenry CR, Walfish PG, Rosen IB (1993) Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surgeon (59):415-419

    Google Scholar 

  89. Barbesino G, Tomer Y, Concepcion E, Davies TF, Greenberg DA (1998) Linkage analysis of candidate genes in autoimmune thyroid disease: 1. Selected immunoregulatory genes. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab 83(5):1580-1584

    Article  PubMed  CAS  Google Scholar 

  90. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L (1994) An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 8(1):83-87

    Article  PubMed  CAS  Google Scholar 

  91. Riddle O, Bates RW, Dykshorn S (1933) The preparation, identification and assay of prolactin. A hormone of the anterior pituitary. Am J Physiol (105):191-196

    Google Scholar 

  92. Frantz AG, Kleinberg DL (1970) Prolactin: evidence that it is separate from growth hormone in human blood. Science 170(959):745-747

    Article  PubMed  CAS  Google Scholar 

  93. Lewis UJ, Singh RN, Sinha YN, VanderLaan WP (1971) Electrophoretic evidence for human prolactin. J Clin Endocrinol Metab 33(1):153-156

    Article  PubMed  CAS  Google Scholar 

  94. Hwang P, Guyda H, Friesen H (1972) Purification of human prolactin. J Biol Chem 247(7):1955-1958

    PubMed  CAS  Google Scholar 

  95. Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523-1631

    PubMed  CAS  Google Scholar 

  96. Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39(5):928-935

    Article  PubMed  CAS  Google Scholar 

  97. Guyda JH (1975) Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations. J Clin Endocrinol Metab 41(5):953-967

    Article  PubMed  CAS  Google Scholar 

  98. Farkouh NH, Packer MG, Frantz AG (1979) Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 48(6):1026-1032

    Article  PubMed  CAS  Google Scholar 

  99. Benveniste R, Helman JD, Orth DN, McKenna TJ, Nicholson WE, Rabinowitz D (1979) Circulating big human prolactin: conversion to small human prolactin by reduction of disulfide bonds. J Clin Endocrinol Metab 48(5):883-886

    Article  PubMed  CAS  Google Scholar 

  100. Jackson RD, Wortsman J, Malarkey WB (1985) Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 61(2):258-264

    Article  PubMed  CAS  Google Scholar 

  101. Fraser IS, Lun ZG, Zhou JP et al (1989) Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J Clin Endocrinol Metab 69(3):585-592

    Article  PubMed  CAS  Google Scholar 

  102. Larrea F, Escorza A, Valero A, Hernandez L, Cravioto MC, Diaz-Sanchez V (1989) Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function. J Clin Endocrinol Metab 68(5):982-987

    Article  PubMed  CAS  Google Scholar 

  103. Lewis UJ, Singh RN, Sinha YN, Vanderlaan WP (1985) Glycosylated human prolactin. Endocrinology 116(1):359-363

    Article  PubMed  CAS  Google Scholar 

  104. Markoff E, Lee DW (1985) Glycosylated prolactin is a major circulating variant in human serum. J Clin Endocrinol Metab (65):1102-1106

    Google Scholar 

  105. Markoff E, Lee DW, Hollingsworth DR (1988) Glycosated and nonglycosated prolactin in serum druring pregnancy. J Clin Endocrinol Metab (67):519-523

    Google Scholar 

  106. Pellegrini I, Gunz G, Ronin C et al (1988) Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms. Endocrinology 122(6):2667-2674

    Article  PubMed  CAS  Google Scholar 

  107. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19(3):225-268

    Article  PubMed  CAS  Google Scholar 

  108. Goldsmith PC, Cronin MJ, Weiner RI (1979) Dopamine receptor sites in the anterior pituitary. J Histochem Cytochem 27(8):1205-1207

    PubMed  CAS  Google Scholar 

  109. Quigley ME, Judd SJ, Gilliland GB, Yen SS (1979) Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 48(4):718-720

    Article  PubMed  CAS  Google Scholar 

  110. Quigley ME, Judd SJ, Gilliland GB, Yen SS (1980) Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma. J Clin Endocrinol Metab 50(6):994-998

    Article  PubMed  CAS  Google Scholar 

  111. De Leo V, Petraglia F, Bruno MG, Lanzetta D, Inaudi P, D'Antona N (1989) Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy. Gynecol Obstet Invest 27(2):94-98

    Article  PubMed  Google Scholar 

  112. Lachelin GC, Leblanc H, Yen SS (1977) The inhibitory effect of dopamine agonists on LH release in women. J Clin Endocrinol Metab 44(4):728-732

    Article  PubMed  CAS  Google Scholar 

  113. Hill MK, Macleod RM, Orcutt P (1976) Dibutyryl cyclic AMP, adenosine and guanosine blockade of the dopamine, ergocryptine and apomorphine inhibition of prolactin release in vitro. Endocrinology 99(6):1612-1617

    Article  PubMed  CAS  Google Scholar 

  114. Lemberger L, Crabtree RE (1979) Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist. Science 205(4411):1151-1153

    Article  PubMed  CAS  Google Scholar 

  115. Braund W, Roeger DC, Judd SJ (1984) Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms. J Clin Endocrinol Metab 58(2):293-297

    Article  PubMed  CAS  Google Scholar 

  116. Grossman A, Delitala G, Yeo T, Besser GM (1981) GABA and muscimol inhibit the release of prolactin from dispersed rat anterior pituitary cells. Neuroendocrinology 32(3):145-149

    Article  PubMed  CAS  Google Scholar 

  117. Gudelsky GA, Apud JA, Masotto C et al (1983) Ethanolamine-O-sulfate enhances gamma-aminobutyric acid secretion into hypophysial portal blood and lowers serum prolactin concentrations. Neuroendocrinology 37(5):397-399

    Article  PubMed  CAS  Google Scholar 

  118. Melis GB, Paoletti AM, Mais V et al (1982) The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects. J Clin Endocrinol Metab 54(3):485-489

    Article  PubMed  CAS  Google Scholar 

  119. Melis GB, Fruzzetti F, Paoletti AM et al (1984) Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women. J Clin Endocrinol Metab 58(1):201-205

    Article  PubMed  CAS  Google Scholar 

  120. Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87(18):6934-6938

    Article  PubMed  CAS  Google Scholar 

  121. Hu ZZ, Zhuang L, Meng J, Dufau ML (1998) Transcriptional regulation of the generic promoter III of the rat prolactin receptor gene by C/EBPbeta and Sp1. J Biol Chem 273(40):26225-26235

    Article  PubMed  CAS  Google Scholar 

  122. Sassin JF, Frantz AG, Weitzman ED, Kapen S (1972) Human prolactin: 24-hour pattern with increased release during sleep. Science 177(55):1205-1207

    Article  PubMed  CAS  Google Scholar 

  123. Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab 37(3):436-440

    Article  PubMed  CAS  Google Scholar 

  124. Carandente F, Angeli A, Candiani GB et al (1989) Rhythms in the ovulatory cycle. 1st: Prolactin. Chronobiological Research Group on Synthetic Peptides in Medicine. Chronobiologia 16(1):35-44

    PubMed  CAS  Google Scholar 

  125. Pansini F, Bergamini CM, Cavallini AR et al (1987) Prolactinemia during the menstrual cycle. A possible role for prolactin in the regulation of ovarian function. Gynecol Obstet Invest 23(3):172-176

    Article  PubMed  CAS  Google Scholar 

  126. Pansini F, Bianchi A, Zito V et al (1983) Blood prolactin levels: influence of age, menstrual cycle and oral contraceptives. Contraception 28(3):201-207

    Article  PubMed  CAS  Google Scholar 

  127. Franks S, Gharani N, Waterworth D et al (1997) The genetic basis of polycystic ovary syndrome. Hum Reprod 12(12):2641-2648

    Article  PubMed  CAS  Google Scholar 

  128. Jacobs HS, Hull MG, Murray MA, Franks S (1975) Therapy-orientated diagnosis of secondary amenorrhoea. Horm Res 6(4):268-287

    Article  PubMed  CAS  Google Scholar 

  129. Bohnet HG, Dahlen HG, Wuttke W, Schneider HP (1976) Hyperprolactinemic anovulatory syndrome. J Clin Endocrinol Metab 42(1):132-143

    Article  PubMed  CAS  Google Scholar 

  130. Franks S, Murray MA, Jequier AM, Steele SJ, Nabarro JD, Jacobs HS (1975) Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) 4(6):597-607

    Article  CAS  Google Scholar 

  131. Boyar RM, Kapen S, Finkelstein JW et al (1974) Hypothalamic-pituitary function in diverse hyperprolactinemic states. J Clin Invest 53(6):1588-1598

    Article  PubMed  CAS  Google Scholar 

  132. Moult PJ, Rees LH, Besser GM (1982) Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy. Clin Endocrinol (Oxf) 16(2):153-162

    Article  CAS  Google Scholar 

  133. Buckman MT, Peake GT, Srivastava L (1981) Patterns of spontaneous LH release in normo- and hyperprolactinaemic women. Acta Endocrinol (Copenh) 97(3):305-310

    CAS  Google Scholar 

  134. Aono T, Miyake A, Yasuda TS, Koike K, Kurachi K (1979) Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea. Acta Endocrinol (Copenh) 91(4):591-600

    CAS  Google Scholar 

  135. Travaglini P, Ambrosi B, Beck-Peccoz P et al (1978) Hypothalamic-pituitary-ovarian function in hyperprolactinemic women. J Endocrinol Invest 1(1):39-45

    PubMed  CAS  Google Scholar 

  136. Glass MR, Shaw RW, Butt WR, Edwards RL, London DR (1975) An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea. Br Med J 3(5978):274-275

    Article  PubMed  CAS  Google Scholar 

  137. Koike J, Aono T, Tsutsumi H, Miyake A, Kurachi K (1982) Restoration of oestrogen-positive feedback effect on LH release in women with prolactinoma by transsphenoidal surgery. Acta Endocrinol (Copenh) 100(4):492-498

    CAS  Google Scholar 

  138. Rakoff J, VandenBerg G, Siler TM, Yen SS (1974) An integrated direct functional test of the adenohypophysis. Am J Obstet Gynecol 119(3):358-368

    PubMed  CAS  Google Scholar 

  139. Zarate A, Jacobs LS, Canales ES et al (1973) Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine. J Clin Endocrinol Metab 37(6):855-859

    Article  PubMed  CAS  Google Scholar 

  140. McNatty KP (1979) Relationship between plasma prolactin and the endocrine microenvironment of the developing human antral follicle. Fertil Steril 32(4):433-438

    PubMed  CAS  Google Scholar 

  141. Dorrington J, Gore-Langton RE (1981) Prolactin inhibits oestrogen synthesis in the ovary. Nature 290(5807):600-602

    Article  PubMed  CAS  Google Scholar 

  142. Cutie E, Andino NA (1988) Prolactin inhibits the steroidogenesis in midfollicular phase human granulosa cells cultured in a chemically defined medium. Fertil Steril 49(4):632-637

    PubMed  CAS  Google Scholar 

  143. Adashi EY, Resnick CE (1987) Prolactin as an inhibitor of granulosa cell luteinization: implications for hyperprolactinemia-associated luteal phase dysfunction. Fertil Steril 48(1):131-139

    PubMed  CAS  Google Scholar 

  144. Soto EA, Tureck RW, Strauss JF 3rd (1985) Effects of prolactin on progestin secretion by human granulosa cells in culture. Biol Reprod 32(3):541-545

    Article  PubMed  CAS  Google Scholar 

  145. Demura R, Ono M, Demura H et al (1985) Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17β-estradol in the human ovary. J Clin Endocrinol Metab (54):1246-1250

    Google Scholar 

  146. Kleinberg DL, Noel GL, Frantz AG (1977) Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 296(11):589-600

    Article  PubMed  CAS  Google Scholar 

  147. Tolis G, Somma M, Van Campenhout J, Friesen H (1974) Prolactin secretion in sixty-five patients with galactorrhea. Am J Obstet Gynecol 118(1):91-101

    PubMed  CAS  Google Scholar 

  148. Boyd AE III, Reichlin S, Turksoy RN (1977) Galactorrhea-amenorrhea syndrome: diagnosis and therapy. Ann Intern Med 87(2):165-175

    PubMed  CAS  Google Scholar 

  149. Schlechte J, Sherman B, Halmi N et al (1980) Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study. Endocr Rev 1(3):295-308

    Article  PubMed  CAS  Google Scholar 

  150. Minakami H, Abe N, Oka N, Kimura K, Tamura T, Tamada T (1988) Prolactin release in polycystic ovarian syndrome. Endocrinol Jpn 35(2):303-310

    PubMed  CAS  Google Scholar 

  151. Murdoch AP, Dunlop W, Kendall-Taylor P (1986) Studies of prolactin secretion in polycystic ovary syndrome. Clin Endocrinol (Oxf) 24(2):165-175

    Article  CAS  Google Scholar 

  152. Lythgoe K, Dotson R, Peterson CM (1995) Multiple endocrine neoplasia presenting as primary amenorrhea: a case report. Obstet Gynecol 86(4 Pt 2):683-686

    Article  PubMed  CAS  Google Scholar 

  153. Burgess JR, Shepherd JJ, Parameswaran B et al (1996) Spectrum of pituritary disease in multiple endocrine neoplasia type 1 (MEN-1): clinical, bichemical, and radiologic features of pituitary disease in a large MEN-1 kindred. J Clin Endocrinol Metab (81):2642-2646

    Google Scholar 

  154. Bohler HC Jr, Jones EE, Brines ML (1994) Marginally elevated prolactin levels require magnetic resonance imaging and evaluation for acromegaly. Fertil Steril 61(6):1168-1170

    PubMed  Google Scholar 

  155. Gonsky R, Herman V, Melmed S, Fagin J (1991) Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 5(11):1687-1695

    Article  PubMed  CAS  Google Scholar 

  156. Sisam DA, Sheehan JP, Sheeler LR (1987) The natural history of untreated microprolactinomas. Fertil Steril 48(1):67-71

    PubMed  CAS  Google Scholar 

  157. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A (1989) The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68(2):412-418

    Article  PubMed  CAS  Google Scholar 

  158. Weiss MH, Wycoff RR, Yadley R, Gott P, Feldon S (1983) Bromocriptine treatment of prolactin-secreting tumors: surgical implications. Neurosurgery 12(6):640-642

    Article  PubMed  CAS  Google Scholar 

  159. NIH Publication 02-3924. 2002

    Google Scholar 

  160. Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V (1988) Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 67(1):124-130

    Article  PubMed  CAS  Google Scholar 

  161. Turner TH, Cookson JC, Wass JA, Drury PL, Price PA, Besser GM (1984) Psychotic reactions during treatment of pituitary tumours with dopamine agonists. Br Med J (Clin Res Ed) 289(6452):1101-1103

    Article  CAS  Google Scholar 

  162. Katz E, Weiss BE, Hassell A, Schran HF, Adashi EY (1991) Increased circulating levels of bromocriptine after vaginal compared with oral administration. Fertil Steril 55(5):882-884

    PubMed  CAS  Google Scholar 

  163. Jeffcoate WJ, Pound N, Sturrock ND, Lambourne J (1996) Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 45(3):299-303

    Article  CAS  Google Scholar 

  164. Passos VQ, Souza JJ, Musolino NR, Bronstein MD (2002) Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab 87(8):3578-3582

    Article  PubMed  CAS  Google Scholar 

  165. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349(21):2023-2033

    Article  PubMed  CAS  Google Scholar 

  166. Biswas M, Smith J, Jadon D et al (2005) Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin Endocrinol (Oxf) 63(1):26-31

    Article  CAS  Google Scholar 

  167. Abram M, Brue T, Morange I, Girard N, Guibout M, Jaquet P (1992) Pituitary tumor syndrome and hyperprolactinemia in peripheral hypothyroidism. Ann Endocrinol (Paris) 53(5-6):215-223

    CAS  Google Scholar 

  168. Nagel TC, Freinkel N, Bell RH, Friesen H, Wilber JF, Metzger BE (1973) Gynecomastia, prolactin, and other peptide hormones in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab 36(3):428-432

    Article  PubMed  CAS  Google Scholar 

  169. Chirito E, Bonda A, Friesen HG (1972) Prolactin in renal failure. Clin Res (20):423

    Google Scholar 

  170. Lloyd RV (1983) Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 113(2): p. 198-206

    PubMed  CAS  Google Scholar 

  171. Scheithauer BW et al. (1990) The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65(4):461-474

    PubMed  CAS  Google Scholar 

  172. Weil C (1986) The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review. Curr Med Res Opin 10(3):172-195

    PubMed  CAS  Google Scholar 

  173. Shy KK et al (1983) Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 249(16):2204-2207

    PubMed  CAS  Google Scholar 

  174. Corenblum B and Taylor PJ (1988) Idiopathic hyperprolactinemia may include a distinct entity with a natural history different from that of prolactin adenomas. Fertil Steril 49(3):544-546

    PubMed  CAS  Google Scholar 

  175. Corenblum B and Donovan L (1993) The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 59(3):671-673

    PubMed  CAS  Google Scholar 

  176. Scheithauer BW et al (1989) Effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 64(9):1077-1084

    PubMed  CAS  Google Scholar 

  177. Ruiz-Velasco V, Tolis G (1984) Pregnancy in hyperprolactinemic women. Fertil Steril 41(6):793-805

    PubMed  CAS  Google Scholar 

  178. Turkalj I, Braun P, Krupp P (1982) Surveillance of bromocriptine in pregnancy. JAMA 247(11):1589-1591

    Article  PubMed  CAS  Google Scholar 

  179. Kirsch C, Iffy L, Zito GE, McArdle JJ (2001) The role of hypertension in bromocriptine-related puerperal intracranial hemorrhage. Neuroradiology 43(4):302-304

    Article  PubMed  CAS  Google Scholar 

  180. Iffy L, Lindenthal J, McArdle JJ, Ganesh V (1996) Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression. Isr J Med Sci 32(5):309-312

    PubMed  CAS  Google Scholar 

  181. Iffy L, McArdle JJ, Ganesh V (1996) Intracerebral hemorrhage in normotensive mothers using bromocriptine postpartum. Zentralbl Gynakol 118(7):392-395

    PubMed  CAS  Google Scholar 

  182. Gittelman DK (1991) Bromocriptine associated with postpartum hypertension, seizures, and pituitary hemorrhage. Gen Hosp Psychiatry 13(4):278-280

    Article  PubMed  CAS  Google Scholar 

  183. Katz M, Kroll D, Pak I, Osimoni A, Hirsch M (1985) Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine. Obstet Gynecol 66(6):822-824

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Utah Center for Reproductive Medicine, Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA

    Shawn Gurtcheff & C. Matthew Peterson

Authors
  1. Shawn Gurtcheff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Matthew Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Matthew Peterson .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Utah, Arapeen Dr. 675, Salt Lake City, 84108, USA

    Douglas T. Carrell

  2. School of Medicine, University of Utah, North Medical Drive 50, Salt Lake City, 84132, USA

    C. Matthew Peterson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Gurtcheff, S., Peterson, C.M. (2010). Common Endocrinopathies in Reproductive Endocrinology. In: Carrell, D., Peterson, C. (eds) Reproductive Endocrinology and Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1436-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1436-1_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1435-4

  • Online ISBN: 978-1-4419-1436-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation